首页> 外文期刊>Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] >The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis
【24h】

The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis

机译:超胰腺感染在急性胰腺炎中预测严重程度和局部并发症中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundThe aim of our study was to determine the risk factors for extrapancreatic infection (EPI) occurrence and its predictive power for assessing severity and local complications in acute pancreatitis including infected pancreatic necrosis (IPN). MethodsClinical data of 176 AP patients prospectively enrolled were analysed. EPI analysed were bacteraemia, lung infection, urinary tract infection and catheter line infection. Risk factors analysed were: Leukocyte count, C-reactive protein, liver function test, serum calcium, serum glucose, Blood urea nitrogen, mean arterial pressure at admission, total parenteral nutrition (TPN), enteral nutrition, hypotension, respiratory, cardiovascular and renal failure at admission, persistent systemic inflammatory response (SIRS) and intrapancreatic necrosis. Severity outcomes assessed were defined according to the Atlanta Criteria definition for acute pancreatitis. The predictive accuracy of EPI for morbidity and mortality was measured using area-under-the-curve (AUC) receiver-operating characteristics. ResultsForty-four cases of EPI were found (25%). TPN (OR:9.2 CI95%: 3.3–25.7), APACHE-II>8 (OR:6.2 CI95%:2.48–15.54) and persistent SIRS (OR:2.9 CI95%: 1.1–7.8), were risk factors related with EPI. Bacteraemia, when compared with others EPI, showed the best accuracy in predicting significantly persistent organ failure (AUC:0.76, IC95%:0.64–0.88), ICU admission (AUC:0.80 IC95%:0.65–0.94), and death (AUC:0.73 CI95%:0.54–0.91); and for local complications including IPN (AUC:0.72 CI95%:0.53–0.92) as well. Besides, it was also needed for an interventional procedure against necrosis (AUC:0.74 IC95%: 0.57–0.91). When bacteraemia and IPN occurs, bacteraemia preceded infected necrosis in all cases. On multivariate analysis, risk factor for IPN were lung infection (OR:6.25 CI95%1.1-35.7 p?=?0.039) and TPN (OR:22.0CI95%:2.4–205.8, p?=?0.007), and for mortality were persistent SIRS at first week (OR: 22.9 CI95%: 2.6–203.7, p?=?0.005) and Lung infection (OR: 9.7 CI95%: 1.7–53.8). ConclusionIn our study, EPI, played a role in predicting the severity and local complications in acute pancreatitis.
机译:背景技术我们研究的目的是确定外包感染(EPI)发生的危险因素及其预测能力,用于评估急性胰腺炎中的严重程度和局部并发症,包括受感染的胰腺坏死(IPN)。分析了176例患者的方法临床数据进行了预期注册。 EPI分析是菌血症,肺部感染,尿路感染和导管感染。分析的危险因素是:白细胞计数,C反应蛋白,肝功能试验,血清钙,血清葡萄糖,血尿尿素氮,平均动脉压入院,总肠外营养(TPN),肠内营养,低血压,呼吸道,心血管和肾入院失败,持续全身性炎症反应(SIRS)和血症患者坏死。评估的严重程度结果是根据急性胰腺炎的亚特兰大标准定义定义的。使用曲线下(AUC)接收器操作特性测量EPI的预测精度和发病率和死亡率。发现了4例EPI病例(25%)。 TPN(或:9.2 CI95%:3.3-25.7),Apache-II> 8(或:6.2 CI95%:2.48-15.54)和持久立师(或:2.9 CI95%:1.1-7.8),是与EPI相关的风险因素。与其他EPI相比,菌血症在预测明显持续的器官衰竭(AUC:0.76,IC95%:0.64-0.88),ICU入院(AUC:0.80 IC95%:0.65-0.94)和死亡(AUC: 0.73 CI95%:0.54-0.91);以及局部并发症,包括IPN(AUC:0.72 CI95%:0.53-0.92)。此外,还需要对坏死的介入程序(AUC:0.74 IC95%:0.57-0.91)。当菌血症和IPN发生时,菌血症在所有情况下都是感染的坏死。在多变量分析中,IPN的危险因素是肺部感染(或:6.25CI95%1.1-35.7 p?= 0.039)和TPN(或:22.0ci95%:2.4-205.8,p?= 0.007),并且用于死亡率第一周持久立师(或:22.9 CI95%:2.6-203.7,P?= 0.005)和肺部感染(或:9.7 CI95%:1.7-53.8)。结论我们的研究,EPI,在预测急性胰腺炎中的严重程度和局部并发症方面发挥了作用。

著录项

  • 来源
  • 作者单位

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

    Department of Hepato-Pancreato-Biliary and Transplant Surgery Hospital Universitari Vall d'Hebron;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号